5-(Acetamido)-N,N’-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide CAS:31127-80-7

5-(Acetamido)-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide, commonly known as a triiodinated contrast medium, serves a crucial role in medical imaging procedures, particularly in computed tomography (CT) scans. As a contrast agent, it is administered intravenously to enhance the visibility of blood vessels, organs, and tissues within the body, allowing for improved diagnostic accuracy in various medical conditions. In CT imaging, the compound's high atomic weight and iodine content enable it to absorb X-rays, resulting in increased contrast between different types of tissues. This heightened contrast facilitates the visualization of anatomical structures and pathological changes, aiding radiologists and healthcare professionals in identifying and diagnosing a wide range of diseases and injuries. Furthermore, the application of 5-(Acetamido)-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide extends to angiography, a medical imaging technique used to examine blood vessels throughout the body. By selectively opacifying blood vessels, the contrast agent allows for precise visualization of vascular anatomy, assisting in the detection of abnormalities such as aneurysms, stenoses, and embolisms. Additionally, this contrast medium plays a critical role in urography, which involves imaging of the urinary tract, including the kidneys, ureters, and bladder. By enhancing the delineation of urinary structures, the compound aids in the assessment of renal function, detection of urinary obstructions, and identification of abnormalities within the genitourinary system. Moreover, 5-(Acetamido)-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide finds application in various specialized CT examinations, including cardiac imaging and neuroimaging. Its ability to improve tissue contrast and vascular visualization contributes to the accurate evaluation and diagnosis of cardiovascular conditions, neurological disorders, and other complex medical presentations. In conclusion, the use of 5-(Acetamido)-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide as a contrast agent in medical imaging, particularly in CT scans, underscores its pivotal role in facilitating accurate diagnosis and treatment planning across a wide spectrum of medical specialties, ultimately contributing to improved patient care and outcomes.